D. Strøbæk

发表

Inhibitory Gating Modulation of Small Conductance Ca2+-Activated K+ Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons

D. Strøbæk, C. Hougaard, T. H. Johansen, 2006, Molecular Pharmacology.

Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells

D. Strøbæk, T. Dyhring, D. Peters, 2014, Brain Research.

Kv7 channels as targets for anti-epileptic and psychiatric drug-development.

D. Strøbæk, C. Hougaard, P. Christophersen, 2014, European journal of pharmacology.

NS 19504 : A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions s

D. Strøbæk, C. Hougaard, P. Christophersen, 2014 .

A Positive Modulator of KCa2 and KCa3 Channels, 4,5-Dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591), Inhibits Bladder Afferent Firing in Vitro and Bladder Overactivity in Vivo

K. Thor, A. Bookout, D. Strøbæk, 2009, Journal of Pharmacology and Experimental Therapeutics.

Stable expression of the human large‐conductance Ca2+‐activated K+ channel α‐ and β‐subunits in HEK293 cells

D. Strøbæk, P. Christophersen, T. Johansen, 1997 .

Chloride channel blockers inhibit iNOS expression and NO production in IFNγ-stimulated microglial BV2 cells

D. Strøbæk, P. Christophersen, L. Rønn, 2009, Brain Research.

A high-throughput screening campaign for detection of ca(2+)-activated k(+) channel activators and inhibitors using a fluorometric imaging plate reader-based tl(+)-influx assay.

D. Strøbæk, P. Christophersen, T. Dyhring, 2013, Assay and drug development technologies.

A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges.

N. Absalom, D. Strøbæk, P. Ahring, 2016, Pharmacological research.

Retroviral glycoprotein-mediated immune suppression via the potassium channel KCa3.1 - A new strategy for amelioration of inflammatory bowel diseases.

D. Strøbæk, P. Christophersen, M. Laska, 2022, Clinical immunology.

Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+‐activated K+ channels

D. Strøbæk, C. Hougaard, T. H. Johansen, 2007, British journal of pharmacology.

Pharmacological characterization of small‐conductance Ca2+‐activated K+ channels stably expressed in HEK 293 cells

D. Strøbæk, P. Christophersen, S. Olesen, 2000, British journal of pharmacology.

P2‐purinoceptor‐mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells

D. Strøbæk, P. Christophersen, S. Dissing, 1996, British journal of pharmacology.

CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate1

D. Strøbæk, C. Hougaard, E. Nielsen, 2012, Front. Pharmacol..

NS6180, a new KCa3.1 channel inhibitor prevents T‐cell activation and inflammation in a rat model of inflammatory bowel disease

D. Strøbæk, P. Christophersen, H. Wulff, 2013, British journal of pharmacology.

Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2.

D. Strøbæk, C. Hougaard, P. Christophersen, 2012, Chemistry & biology.

Specific Enhancement of SK Channel Activity Selectively Potentiates the Afterhyperpolarizing Current IAHP and Modulates the Firing Properties of Hippocampal Pyramidal Neurons*

D. Strøbæk, C. Hougaard, P. Pedarzani, 2005, Journal of Biological Chemistry.

KCNQ4 channel activation by BMS-204352 and retigabine

D. Strøbæk, P. Christophersen, S. Olesen, 2001, Neuropharmacology.

Characterization of a novel high-potency positive modulator of K(v)7 channels.

Palle Christophersen, D. Strøbæk, C. Hougaard, 2013, European journal of pharmacology.

Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels

D. Strøbæk, M. Korsgaard, N. Mirza, 2005, Journal of Pharmacology and Experimental Therapeutics.

Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.

A. Silahtaroglu, D. Strøbæk, P. Christophersen, 1998, American journal of physiology. Cell physiology.

Activation of the human, intermediate-conductance, Ca2+-activated K+ channel by methylxanthines

D. Strøbæk, P. Christophersen, S. Olesen, 2000, Pflügers Archiv.

An ERG Channel Inhibitor from the Scorpion Buthus eupeus*

E. Grishin, D. Strøbæk, Yuliya V. Korolkova, 2001, The Journal of Biological Chemistry.

Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels

D. Strøbæk, C. Hougaard, P. Christophersen, 2009, The European journal of neuroscience.

Corrigendum to “KCNQ4 channel activation by BMS-204352 and retigabine” [Neuropharmacology 40(2001) 888–98]

D. Strøbæk, P. Christophersen, S. Olesen, 2003, Neuropharmacology.

Selective Activation of the SK1 Subtype of Human Small-Conductance Ca2+-Activated K+ Channels by 4-(2-Methoxyphenylcarbamoyloxymethyl)-piperidine-1-carboxylic Acid tert-Butyl Ester (GW542573X) Is Dependent on Serine 293 in the S5 Segment

D. Strøbæk, C. Hougaard, P. Christophersen, 2009, Molecular Pharmacology.

Evidence for a Common Pharmacological Interaction Site on KCa2 Channels Providing Both Selective Activation and Selective Inhibition of the Human KCa2.1 Subtype

D. Strøbæk, C. Hougaard, U. Sørensen, 2012, Molecular Pharmacology.

Synthesis and Structure−Activity Relationship Studies of 2-(N-Substituted)-aminobenzimidazoles as Potent Negative Gating Modulators of Small Conductance Ca2+-Activated K+ Channels

D. Strøbæk, C. Hougaard, U. Sørensen, 2008 .

Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent.

D. Strøbæk, P. Christophersen, S. Olesen, 1999, Biochimica et biophysica acta.

NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions

D. Strøbæk, C. Hougaard, P. Christophersen, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Cloning, expression, and distribution of a Ca(2+)-activated K+ channel beta-subunit from human brain.

D. Strøbæk, J. Tseng-Crank, T. Johansen, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Negative Gating Modulation by (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) Depends on Residues in the Inner Pore Vestibule: Pharmacological Evidence of Deep-Pore Gating of KCa2 Channels

D. P. Jenkins, D. Strøbæk, C. Hougaard, 2011, Molecular Pharmacology.

CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate1

D. Strøbæk, C. Hougaard, E. Nielsen, 2012, Front. Pharmacol..

The Ca2+-activated K+ channel of intermediate conductance: a molecular target for novel treatments?

D. Strøbæk, P. Christophersen, S. Olesen, 2001, Current drug targets.

Modulation of the Ca2+-dependent K+ Channel, hslo, by the Substituted Diphenylurea NS 1608, Paxilline and Internal Ca2+

D. Strøbæk, P. Christophersen, T. Johansen, 1996, Neuropharmacology.

Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels

David A. Brown, D. Strøbæk, C. Hougaard, 2009, The European journal of neuroscience.

KCa 1—KCa5 families

D. Strøbæk, P. Christophersen, S. Olesen, 2009 .